专利检索 cpc:"C12N2770/28033" 第 1 页

1.

发明公开
Compositions and Methods for Antigen Targeting to CD180 审中-公开

公开(公告)号：US20240301364A1

公开(公告)日：2024-09-12

申请号：US18665920

申请日：2024-05-16

申请人： UNIVERSITY OF WASHINGTON

发明人： Edward CLARK , Jay Wesley CHAPLIN

IPC分类号： C12N7/00 , A61K39/00 , A61K39/12 , A61K39/29 , A61K39/385 , A61K47/68 , C07K16/28

CPC分类号： C12N7/00 , A61K39/12 , A61K39/29 , A61K39/385 , A61K47/6811 , A61K47/6849 , C07K16/2896 , A61K2039/55511 , A61K2039/55561 , A61K2039/6056 , C07K2319/40 , C07K2319/74 , C12N2770/24132 , C12N2770/24134 , C12N2770/28033 , Y02A50/30

摘要： The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

2.

发明授权
Compositions and methods for antigen targeting to CD180 有权

公开(公告)号：US12018291B2

公开(公告)日：2024-06-25

申请号：US18063823

申请日：2022-12-09

申请人： UNIVERSITY OF WASHINGTON

发明人： Edward Clark , Jay Wesley Chaplin

IPC分类号： A61K47/40 , A61K39/12 , A61K39/29 , A61K39/385 , A61K47/68 , C07K16/28 , C12N7/00 , A61K39/00

CPC分类号： C12N7/00 , A61K39/12 , A61K39/29 , A61K39/385 , A61K47/6811 , A61K47/6849 , C07K16/2896 , A61K2039/55511 , A61K2039/55561 , A61K2039/6056 , C07K2319/40 , C07K2319/74 , C12N2770/24132 , C12N2770/24134 , C12N2770/28033 , Y02A50/30

摘要： The present invention provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

3.

发明申请
Compositions and Methods for Antigen Targeting to CD180 审中-公开
标题翻译：抗原靶向CD180的组成和方法

公开(公告)号：US20150238630A1

公开(公告)日：2015-08-27

申请号：US14426635

申请日：2013-09-16

申请人： UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

发明人： Edward Clark , Jay Wesley Chaplin

IPC分类号： A61K47/48 , A61K39/12 , C12N7/00 , A61K39/29

CPC分类号： C12N7/00 , A61K39/12 , A61K39/29 , A61K39/385 , A61K47/6811 , A61K47/6849 , A61K2039/55511 , A61K2039/55561 , A61K2039/6056 , C07K16/2896 , C07K2319/40 , C07K2319/74 , C12N2770/24132 , C12N2770/24134 , C12N2770/28033 , Y02A50/386 , Y02A50/394

摘要： The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

摘要翻译： 本限制提供了与异源抗原偶联的CD 180靶向分子的组合物及其在治疗和/或限制疾病中的用途。